Factors Associated with Potassium-Competitive Acid Blocker Non-Response in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease

Masatsugu Okuyama,Kenichi Nakahara,Narika Iwakura,Tomoki Hasegawa,Maizumi Oyama,Ayumi Inoue,Hirotaka Ishizu,Hiroshi Satoh,Yasuhiro Fujiwara

Factors Associated with Potassium-Competitive Acid Blocker Non-Response in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease

2017

Masatsugu Okuyama
Kenichi Nakahara
Narika Iwakura
Tomoki Hasegawa
Maizumi Oyama
Ayumi Inoue
Hirotaka Ishizu
Hiroshi Satoh
Yasuhiro Fujiwara

Background/Aims: Approximately 20-40% of patients with gastroesophageal reflux disease (GERD) are refractory to proton pump inhibitor (PPI) treatment. The acid-in

Keywords:

Gastroenterology
Refractory
Vonoprazan
Endocrinology
Potassium
Internal medicine
Reflux
Pharmacotherapy
Diabetes mellitus
GERD
Proton-pump inhibitor
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations